Massachusetts Financial Services
LYEL icon

Massachusetts Financial Services’s Lyell Immunopharma LYEL Stock Holding History

Massachusetts Financial Services’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-28,866
Closed -$837K – 876
2024
Q2 		$837K Sell
28,866
-48,176
-63% -$2.29M ﹤0.01% 806
2024
Q1 		$3.44M Buy
77,042
+9,308
+14% +$399K ﹤0.01% 697
2023
Q4 		$2.63M Sell
67,734
-426
-0.6% -$15.3K ﹤0.01% 706
2023
Q3 		$2M Sell
68,160
-501
-0.7% -$23.8K ﹤0.01% 719
2023
Q2 		$4.37M Sell
68,661
-909
-1% -$50.3K ﹤0.01% 654
2023
Q1 		$3.28M Buy
69,570
+5,144
+8% +$275K ﹤0.01% 671
2022
Q4 		$4.47M Buy
64,426
+11,431
+22% +$1.14M ﹤0.01% 659
2022
Q3 		$7.77M Buy
52,995
+3,590
+7% +$486K ﹤0.01% 628
2022
Q2 		$6.44M Sell
49,405
-372
-0.7% -$38K ﹤0.01% 638
2022
Q1 		$5.03M Buy
49,777
+1,374
+3% +$166K ﹤0.01% 676
2021
Q4 		$7.49M Sell
48,403
-357
-0.7% -$79.6K ﹤0.01% 682
2021
Q3 		$14.4M Sell
48,760
-636
-1% -$191K ﹤0.01% 644
2021
Q2 		$16M Buy
+49,396
New +$16.2M ﹤0.01% 639

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services's LYEL Position: Q3 2024 in Review

Massachusetts Financial Services sold out of Lyell Immunopharma (LYEL) in Q3 2024, closing a stake of 28,866 shares — an estimated $837K sold.

Massachusetts Financial Services first reported a position in LYEL in Q2 2021 and held it in 13 quarters. The position peaked at $16M in Q2 2021. 117 funds tracked by Wall St. Rank hold LYEL as of Q3 2024.

  • Massachusetts Financial Services reported no remaining Lyell Immunopharma position as of Q3 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 28,866 Lyell Immunopharma shares in Q3 2024, an estimated $837K.
  • Massachusetts Financial Services first reported a position in Lyell Immunopharma in Q2 2021 and held it in 13 quarters.
  • Massachusetts Financial Services's Lyell Immunopharma position peaked at $16M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2024.

Based on Massachusetts Financial Services's 13F filing for Q3 2024, filed 12 Nov 2024.